<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Neurol.</journal-id>
<journal-title>Frontiers in Neurology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Neurol.</abbrev-journal-title>
<issn pub-type="epub">1664-2295</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fneur.2024.1352310</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neurology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Early and late basilar artery thrombectomy time window outcomes</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>Mierzwa</surname> <given-names>Adam T.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="fn0001"><sup>&#x2020;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2594340/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>Rao</surname> <given-names>Rahul</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="fn0001"><sup>&#x2020;</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Al Kasab</surname> <given-names>Sami</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/719972/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Nelson</surname> <given-names>Ashley</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Ortega-Gutierrez</surname> <given-names>Santiago</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/650770/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Vivanco-Suarez</surname> <given-names>Juan</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2280924/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Farooqui</surname> <given-names>Mudassir</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/890693/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Jadhav</surname> <given-names>Ashutosh P.</given-names></name>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Desai</surname> <given-names>Shashvat</given-names></name>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Toth</surname> <given-names>Gabor</given-names></name>
<xref ref-type="aff" rid="aff6"><sup>6</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/301318/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Alrohimi</surname> <given-names>Anas</given-names></name>
<xref ref-type="aff" rid="aff6"><sup>6</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Nguyen</surname> <given-names>Thanh N.</given-names></name>
<xref ref-type="aff" rid="aff7"><sup>7</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/9410/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Klein</surname> <given-names>Piers</given-names></name>
<xref ref-type="aff" rid="aff7"><sup>7</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Abdalkader</surname> <given-names>Mohamad</given-names></name>
<xref ref-type="aff" rid="aff7"><sup>7</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/728847/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Salahuddin</surname> <given-names>Hisham</given-names></name>
<xref ref-type="aff" rid="aff8"><sup>8</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Pandey</surname> <given-names>Aditya</given-names></name>
<xref ref-type="aff" rid="aff9"><sup>9</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Wilseck</surname> <given-names>Zachary</given-names></name>
<xref ref-type="aff" rid="aff9"><sup>9</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1676788/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Koduri</surname> <given-names>Sravanthi</given-names></name>
<xref ref-type="aff" rid="aff9"><sup>9</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Vora</surname> <given-names>Nirav</given-names></name>
<xref ref-type="aff" rid="aff10"><sup>10</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Aladamat</surname> <given-names>Nameer</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Gharaibeh</surname> <given-names>Khaled</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2594915/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Afreen</surname> <given-names>Ehad</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Zaidi</surname> <given-names>Syed</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/78893/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Jumaa</surname> <given-names>Mouhammad</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/678905/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Neurology, University of Toledo College of Medicine and Life Sciences</institution>, <addr-line>Toledo, OH</addr-line>, <country>United States</country></aff>
<aff id="aff2"><sup>2</sup><institution>Promedica Stroke Network</institution>, <addr-line>Toledo, OH</addr-line>, <country>United States</country></aff>
<aff id="aff3"><sup>3</sup><institution>Department of Neurology and Neurosurgery, Medical University of South Carolina</institution>, <addr-line>Charleston, SC</addr-line>, <country>United States</country></aff>
<aff id="aff4"><sup>4</sup><institution>University of Iowa</institution>, <addr-line>Iowa City, IA</addr-line>, <country>United States</country></aff>
<aff id="aff5"><sup>5</sup><institution>Barrow Neurological Institute</institution>, <addr-line>Phoenix, AZ</addr-line>, <country>United States</country></aff>
<aff id="aff6"><sup>6</sup><institution>Cleveland Clinic Foundation</institution>, <addr-line>Cleveland, OH</addr-line>, <country>United States</country></aff>
<aff id="aff7"><sup>7</sup><institution>Department of Neurology, Radiology, Boston University Chobanian &#x0026; Avedisian School of Medicine</institution>, <addr-line>Boston, MA</addr-line>, <country>United States</country></aff>
<aff id="aff8"><sup>8</sup><institution>Department of Neurology, Antelope Valley Hospital</institution>, <addr-line>Los Angeles, CA</addr-line>, <country>United States</country></aff>
<aff id="aff9"><sup>9</sup><institution>Department of Neurosurgery, University of Michigan</institution>, <addr-line>Ann Arbor, MI</addr-line>, <country>United States</country></aff>
<aff id="aff10"><sup>10</sup><institution>OhioHealth Riverside Methodist Hospital</institution>, <addr-line>Columbus, OH</addr-line>, <country>United States</country></aff>
<author-notes>
<fn fn-type="edited-by" id="fn0002">
<p>Edited by: Matteo Foschi, Azienda Unit&#x00E0; Sanitaria Locale (AUSL) della Romagna, Italy</p>
</fn>
<fn fn-type="edited-by" id="fn0003">
<p>Reviewed by: Dan-Victor Giurgiutiu, Augusta University, United States; Rossana Tassi, Siena University Hospital, Italy</p>
</fn>
<corresp id="c001">&#x002A;Correspondence: Mouhammad Jumaa, <email>mouhammad.jumaa@utoledo.edu</email></corresp>
<fn fn-type="equal" id="fn0001">
<p><sup>&#x2020;</sup>These authors have contributed equally to this work and share first authorship</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>26</day>
<month>01</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>15</volume>
<elocation-id>1352310</elocation-id>
<history>
<date date-type="received">
<day>07</day>
<month>12</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>02</day>
<month>01</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2024 Mierzwa, Rao, Al Kasab, Nelson, Ortega-Gutierrez, Vivanco-Suarez, Farooqui, Jadhav, Desai, Toth, Alrohimi, Nguyen, Klein, Abdalkader, Salahuddin, Pandey, Wilseck, Koduri, Vora, Aladamat, Gharaibeh, Afreen, Zaidi and Jumaa.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Mierzwa, Rao, Al Kasab, Nelson, Ortega-Gutierrez, Vivanco-Suarez, Farooqui, Jadhav, Desai, Toth, Alrohimi, Nguyen, Klein, Abdalkader, Salahuddin, Pandey, Wilseck, Koduri, Vora, Aladamat, Gharaibeh, Afreen, Zaidi and Jumaa</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec id="sec1">
<title>Importance</title>
<p>Stroke-to-recanalization time is a strong predictor of outcomes in anterior circulation large-vessel occlusion (LVO). The authors aimed to evaluate functional outcomes in early (&#x003C;6&#x2009;h) vs. late (6&#x2013;24&#x2009;h) time windows for thrombectomy-treated basilar artery occlusions.</p>
</sec>
<sec id="sec2">
<title>Methods</title>
<p>Patients were derived from the Posterior Circulation Ischemic Stroke Evaluation: Analyzing Radiographic and Intra-procedural Predictors of Mechanical Thrombectomy (PC-SEARCH) Registry and retrospectively analyzed early and late basilar artery thrombectomy time windows cohorts. Patients were dichotomized based on the last known well and correlated to 90-day functional outcomes (mRS 0&#x2013;3). A multiple logistic regression analysis was performed.</p>
</sec>
<sec id="sec3">
<title>Results</title>
<p>A total of 405 patients were included in this study: 216 and 189 patients in the early and late time windows, respectively. Baseline demographic, stroke, radiographic, and intraprocedural characteristics were similar between the groups. A total of 99 (46%) and 79 (42%) patients in the early and late time windows, respectively, achieved favorable functional outcomes at 90&#x2009;days (<italic>p</italic>&#x2009;=&#x2009;0.41), and multiple logistic regression analysis did not reveal differences between cohorts (OR: 0.74; 95% CI: 0.46&#x2013;1.19; <italic>p</italic>&#x2009;=&#x2009;0.22). Symptomatic hemorrhage (7% vs. 5%; <italic>p</italic>&#x2009;=&#x2009;0.69) and neurological complications (8% vs. 9%; <italic>p</italic>&#x2009;=&#x2009;0.83) were similar between the groups; however, hospital complications were more common in the early time window cohort (22% vs. 13%; <italic>p</italic>&#x2009;=&#x2009;0.01).</p>
</sec>
<sec id="sec4">
<title>Conclusion</title>
<p>The early and late thrombectomy time windows can achieve similar rates of 90-day favorable functional outcomes. However, timely thrombectomy influences the likelihood of achieving excellent functional outcomes (mRS&#x2009;&#x2264;&#x2009;2) within the early time window.</p>
</sec>
</abstract>
<kwd-group>
<kwd>stroke</kwd>
<kwd>basilar artery</kwd>
<kwd>thrombectomy</kwd>
<kwd>large-vessel occlusion</kwd>
<kwd>time window</kwd>
</kwd-group>
<counts>
<fig-count count="3"/>
<table-count count="3"/>
<equation-count count="0"/>
<ref-count count="21"/>
<page-count count="8"/>
<word-count count="4968"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Stroke</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="sec5000">
<title>Highlights</title>
<p>
<list list-type="bullet">
<list-item>
<p>What is already known on this topic&#x2014;Early and late thrombectomy time window in the anterior circulation influences rates of favorable functional outcomes.</p>
</list-item>
<list-item>
<p>What this study adds&#x2014;Patients presenting with acute basilar artery occlusions in the late thrombectomy time window achieve similar rates of favorable functional outcomes.</p>
</list-item>
<list-item>
<p>How this study might affect research, practice, or policy&#x2014;Thrombectomy guidelines should continue recommending the late thrombectomy time window for patient evaluation and treatment.</p>
</list-item>
</list>
</p>
</sec>
<sec sec-type="intro" id="sec5">
<title>Introduction</title>
<p>Last known well (LKW) is a key time metric in stroke neurology. The phrase &#x201C;time is brain&#x201D; is a qualitative statement emphasizing the rapid loss of neurons in the human brain (<xref ref-type="bibr" rid="ref1">1</xref>). Early randomized thrombectomy trials focused on LKW for inclusion criteria to establish the efficacy of thrombectomy in anterior circulation ischemic stroke (<xref ref-type="bibr" rid="ref2">2</xref>). Furthermore, the DAWN and DEFUSE III trials extended this time window in patients with large penumbral volumes (<xref ref-type="bibr" rid="ref3">3</xref>, <xref ref-type="bibr" rid="ref4">4</xref>). As such, the American Stroke Association/American Heart Association (ASA/AHA) guidelines established mechanical thrombectomy (MT) as class 1 and class 2a recommendations for patients presenting in the early and late time windows for anterior circulation large-vessel occlusions, respectively (<xref ref-type="bibr" rid="ref5">5</xref>).</p>
<p>Basilar artery occlusion (BAO), however, was underrepresented in the aforementioned trials and remains a devastating form of ischemic stroke, accounting for up to 10% of large-vessel occlusion (LVO) (<xref ref-type="bibr" rid="ref6">6</xref>). Recently, four randomized clinical trials evaluated the efficacy of thrombectomy compared to the best medical management in patients presenting with acute basilar artery occlusion (<xref ref-type="bibr" rid="ref7 ref8 ref9 ref10">7&#x2013;10</xref>). The BASICS trial enrolled patients within 6&#x2009;h of the estimated time of BAO onset. This trial demonstrated higher rates of good and excellent clinical outcomes, basilar artery patency, and lower mortality in the endovascular group (<xref ref-type="bibr" rid="ref7">7</xref>). The BEST trial evaluated patients presenting within 8&#x2009;h of the estimated time of BAO and demonstrated that the endovascular group had a trend toward functional independence (<xref ref-type="bibr" rid="ref8">8</xref>). The ATTENTION and BAOCHE trials established the superiority of thrombectomy compared to conservative management in the extended time windows of 0&#x2013;12&#x2009;h and 6&#x2013;24&#x2009;h of LKW, respectively (<xref ref-type="bibr" rid="ref9">9</xref>, <xref ref-type="bibr" rid="ref10">10</xref>). Despite these high-level studies, however, the effect of time on the treatment effect of EVT compared to medical management has not been well studied. In this study, the outcomes of basilar artery thrombectomy as a function of LKW time to treatment were evaluated.</p>
</sec>
<sec sec-type="methods" id="sec6">
<title>Methods</title>
<sec id="sec7">
<title>Study design and participants</title>
<p>We performed a comparative cohort study using data from the Posterior Circulation Ischemic Stroke Evaluation: Analyzing Radiographic and Intra-procedural Predictors for Mechanical Thrombectomy (PC-SEARCH Thrombectomy) Registry. The PC-SEARCH Thrombectomy Registry is a collaboration of 8 high-volume comprehensive stroke centers consisting of 518 consecutive patients with acute basilar artery occlusion treated with mechanical thrombectomy from January 2015 to December 2021. Patients were included in the registry if they were over 18&#x2009;years of age and suffered from an acute basilar artery occlusion diagnosed on CTA, MRA, or DSA and treated with mechanical thrombectomy. Patients were excluded if they did not have data for LKW times or primary outcomes. This study was approved under a waiver of informed consent by the local institutional review boards at each participating center and is reported in accordance with the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines (<xref ref-type="bibr" rid="ref11">11</xref>).</p>
<p>Data for the registry were compiled from respective participating sites according to the proposal supplied by the host institution. Each site was responsible for obtaining local IRB approval. The host site received anonymized data and did not require patient consent as no information was required beyond de-identified data.</p>
</sec>
<sec id="sec8">
<title>Study groups and data elements</title>
<p>Patients were divided into two cohorts: (1) Patients arriving at a comprehensive stroke center within 6&#x2009;h or less from their last known well (LKW&#x2009;&#x2264;&#x2009;6) and (2) patients arriving at a comprehensive stroke center greater than 6&#x2009;h but less than 24&#x2009;h from their last known well (LKW 6&#x2013;24&#x2009;h).</p>
<p>De-identified patient baseline, pre-, intra-, and post-procedural data were obtained by the electronic medical records (EMR) of the respective institutions and sent to the host site for compilation and statistical analysis. Patient baseline information included age, gender, self-reported ethnicity, pre-morbid modified ranking scale (mRS), and co-morbidities such as hypertension (HTN), hyperlipidemia (HLD), prior history of stroke, history of smoking, atrial fibrillation, diabetes mellitus, coronary artery disease, and alcohol abuse. Pre-procedural stroke metrics included last known well, presenting National Institute of Health Stroke Scale (NIHSS), location of clot, total and itemized Posterior Circulation Acute Stroke Prognosis Early CT Score (pc-ASPECTS), anterior&#x2013;posterior (AP) collaterals, administration of intravenous thrombolysis, and door-to-thrombolysis times. AP collaterals were defined as a binary variable of being either present or absent.</p>
<p>Intra-procedural characteristics included door-to-puncture and puncture-to-recanalization times, first-pass recanalization (FPR), defined as achieving Thrombolysis in Cerebral Infarction (TICI) 2b or greater (indicating reperfusion &#x003E;50% in the affected vessel) on the first thrombectomy attempt with clot retrieval with no further attempts, total number of passes, first-line device, administration of intra-arterial thrombolysis (IA-tPA), final TICI score, downstream embolization, and retrieval of downstream embolus.</p>
<p>Post-procedural characteristics included 24-h NIHSS and 90-day mRS. Safety data included Safe Implementation of Thrombolysis in Stroke Monitoring Study (SITS-MOST) symptomatic intra-cranial hemorrhage (sICH), SITS-MOST asymptomatic intra-cranial hemorrhage (aICH), post-procedural subarachnoid hemorrhage, non-procedural neurological complications (such as cerebral edema, hydrocephalus, and seizure), and non-procedural hospital complications (itemized by organ system) (<xref ref-type="bibr" rid="ref12">12</xref>).</p>
</sec>
<sec id="sec9">
<title>Primary and secondary outcomes</title>
<p>This study is an analysis of the PC-SEARCH Thrombectomy Registry, and patients were dichotomized into early (LKW&#x2009;&#x2264;&#x2009;6&#x2009;h) and late (LKW&#x2009;&#x003E;&#x2009;6&#x2009;h) thrombectomy time windows. Primary outcomes for this study were favorable (mRS&#x2009;&#x2264;&#x2009;3) and unfavorable (mRS&#x2009;&#x003E;&#x2009;3) functional outcomes at 90&#x2009;days as well as ordinal mRS change between the groups (shift analysis). Secondary outcomes included the percentage of patients achieving mRS 0&#x2013;2 at 90&#x2009;days, 24-h NIHSS, TICI &#x2265;2b, and first-pass recanalization. LKW-to-puncture times (&#x003C;8&#x2009;h) were also correlated to functional outcomes (mRS 0&#x2013;3 and mRS 0&#x2013;2) for patients in the early time window. Safety outcomes included sICH, neurological complications, and hospital complications. A subgroup logistic regression analysis for clot location was performed on the primary outcome.</p>
</sec>
<sec id="sec10">
<title>Statistical analysis</title>
<p>Data were compiled, and univariate analysis was performed with respect to the defined cohorts. Continuous and scale variables were analyzed using mean, median, standard deviation (SD), and interquartile ranges (IQR) as appropriate. A comparison of parametric values was made using Student&#x2019;s <italic>t</italic>-test, and non-parametric values were analyzed via the Mann&#x2013;Whitney <italic>U</italic>-test. Ordinal variables were presented as crude numbers and percentages and analyzed via the chi-squared test or analysis of variance (ANOVA) as appropriate. Simple and multiple logistic regression was performed on baseline, pre-, intra-, and post-procedural predictors and adjusted based on potentially confounding baseline characteristic differences (if the value of <italic>p</italic> was 0.20 or less). A receiver&#x2013;operator curve (ROC) analysis was performed utilizing LKW with respect to 90-day mRS as the state variable. Data were dichotomized based on whether patients had AP collateralization. The early window cohort LKW-to-puncture times, for the first 8&#x2009;h, were set at 10-min interval floors and compared to favorable functional outcomes using multiple logistic regression adjusted for pc-ASPECTS, initial NIHSS, pre-morbid mRS, and proximal clot location.</p>
<p>Statistical significance was defined as two-tailed and reaching a value of <italic>p</italic> of less than 0.05. Analysis was performed using IBM SPSS statistics package 28.</p>
</sec>
</sec>
<sec sec-type="results" id="sec11">
<title>Results</title>
<sec id="sec12">
<title>Baseline characteristics</title>
<p>There are 518 patients in this registry. A total of 113 patients were excluded for missing data, and a total of 405 patients were included in this analysis (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Overall, the mean age was 66 (SD 15.5), 245 (61%) were men, and 302 (75%) were white, 67 (17%) Black, and 3 (1%) Asian people. Two hundred eighty-one (70%) patients had hypertension, 115 (29%) diabetes, 88 (22%) CAD, 183 (45%) HLD, and 101 (25%) patients had atrial fibrillation. There were 286 patients (71%) with a pre-stroke mRS of 0. There were 216 (53%) patients who presented within 6&#x2009;h from LKW while 189 (47%) presented after 6&#x2009;h from LKW. There were no differences between the baseline demographics and vascular risk factors of the two cohorts (<xref ref-type="table" rid="tab1">Table 1</xref>).</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption>
<p>Patient flow chart.</p>
</caption>
<graphic xlink:href="fneur-15-1352310-g001.tif"/>
</fig>
<table-wrap position="float" id="tab1">
<label>Table 1</label>
<caption>
<p>Baseline characteristics.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th/>
<th align="center" valign="top" colspan="2">&#x2264;&#x2009;6 H LKW (<italic>N</italic>&#x2009;=&#x2009;216)</th>
<th align="center" valign="top" colspan="2">6&#x2013;24 H LKW (<italic>N</italic>&#x2009;=&#x2009;189)</th>
<th align="center" valign="top">Value of <italic>p</italic></th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="bottom">Age (Mean, SD)</td>
<td align="center" valign="bottom">66</td>
<td align="center" valign="bottom">(16)</td>
<td align="center" valign="bottom">65</td>
<td align="center" valign="bottom">(15)</td>
<td align="center" valign="bottom">0.349</td>
</tr>
<tr>
<td align="left" valign="bottom">Sex, male (N, %)</td>
<td align="center" valign="bottom">132</td>
<td align="center" valign="bottom">(61.1%)</td>
<td align="center" valign="bottom">113</td>
<td align="center" valign="bottom">(59.8%)</td>
<td align="center" valign="bottom">0.786</td>
</tr>
<tr>
<td align="left" valign="bottom">Ethnicity (N, %)</td>
<td/>
<td/>
<td/>
<td/>
<td align="center" valign="bottom">0.247</td>
</tr>
<tr>
<td align="left" valign="bottom">White</td>
<td align="center" valign="bottom">157</td>
<td align="center" valign="bottom">(72.7%)</td>
<td align="center" valign="bottom">145</td>
<td align="center" valign="bottom">(76.7%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">Black</td>
<td align="center" valign="bottom">43</td>
<td align="center" valign="bottom">(19.9%)</td>
<td align="center" valign="bottom">24</td>
<td align="center" valign="bottom">(12.7%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">Asian</td>
<td align="center" valign="bottom">2</td>
<td align="center" valign="bottom">(0.9%)</td>
<td align="center" valign="bottom">1</td>
<td align="center" valign="bottom">(0.5%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">Other</td>
<td align="center" valign="bottom">8</td>
<td align="center" valign="bottom">(3.7%)</td>
<td align="center" valign="bottom">10</td>
<td align="center" valign="bottom">(5.3%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">Hypertension (N, %)</td>
<td align="center" valign="bottom">148</td>
<td align="center" valign="bottom">(68.5%)</td>
<td align="center" valign="bottom">133</td>
<td align="center" valign="bottom">(70.4%)</td>
<td align="center" valign="bottom">0.687</td>
</tr>
<tr>
<td align="left" valign="bottom">History of stroke (N, %)</td>
<td align="center" valign="bottom">41</td>
<td align="center" valign="bottom">(19.0%)</td>
<td align="center" valign="bottom">35</td>
<td align="center" valign="bottom">(18.5%)</td>
<td align="center" valign="bottom">0.870</td>
</tr>
<tr>
<td align="left" valign="bottom">Smoking (N, %)</td>
<td align="center" valign="bottom">61</td>
<td align="center" valign="bottom">(28.2%)</td>
<td align="center" valign="bottom">65</td>
<td align="center" valign="bottom">(34.4%)</td>
<td align="center" valign="bottom">0.169</td>
</tr>
<tr>
<td align="left" valign="bottom">Atrial fibrillation (N, %)</td>
<td align="center" valign="bottom">60</td>
<td align="center" valign="bottom">(27.8%)</td>
<td align="center" valign="bottom">41</td>
<td align="center" valign="bottom">(21.7%)</td>
<td align="center" valign="bottom">0.158</td>
</tr>
<tr>
<td align="left" valign="bottom">Diabetes mellitus (N, %)</td>
<td align="center" valign="bottom">69</td>
<td align="center" valign="bottom">(31.9%)</td>
<td align="center" valign="bottom">46</td>
<td align="center" valign="bottom">(24.3%)</td>
<td align="center" valign="bottom">0.090</td>
</tr>
<tr>
<td align="left" valign="bottom">Coronary artery disease (N, %)</td>
<td align="center" valign="bottom">42</td>
<td align="center" valign="bottom">(19.4%)</td>
<td align="center" valign="bottom">46</td>
<td align="center" valign="bottom">(24.3%)</td>
<td align="center" valign="bottom">0.233</td>
</tr>
<tr>
<td align="left" valign="bottom">Alcohol abuse (N, %)</td>
<td align="center" valign="bottom">14</td>
<td align="center" valign="bottom">(6.5%)</td>
<td align="center" valign="bottom">10</td>
<td align="center" valign="bottom">(5.3%)</td>
<td align="center" valign="bottom">0.605</td>
</tr>
<tr>
<td align="left" valign="bottom">Hyperlipidemia (N, %)</td>
<td align="center" valign="bottom">97</td>
<td align="center" valign="bottom">(44.9%)</td>
<td align="center" valign="bottom">86</td>
<td align="center" valign="bottom">(45.5%)</td>
<td align="center" valign="bottom">0.904</td>
</tr>
<tr>
<td align="left" valign="bottom">Pre-stroke mRS of 0 (N, %)</td>
<td align="center" valign="bottom">144</td>
<td align="center" valign="bottom">(66.7%)</td>
<td align="center" valign="bottom">142</td>
<td align="center" valign="bottom">(75.1%)</td>
<td align="center" valign="bottom">0.342</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Overall, patients presented to a comprehensive stroke center at a median (IQR) of 335&#x2009;min (90&#x2013;667) with a median NIHSS of 17 (IQR 9&#x2013;26). Patients had a favorable median (IQR) pc-ASPECTS of 9 (8&#x2013;10) and 178 (44%) patients had anterior&#x2013;posterior collateralization. One hundred two (25%) patients received IV thrombolysis. Overall, there were no significant differences in stroke characteristics between the early and late time windows except for numerically higher NIHSS (20 vs. 16; <italic>p</italic>&#x2009;=&#x2009;0.07) and a significantly higher percentage of patients who received IV thrombolysis (40% vs. 8%; <italic>p</italic>&#x2009;&#x003C;&#x2009;0.001) in the early vs. late time windows, respectively (<xref ref-type="table" rid="tab2">Table 2</xref>).</p>
<table-wrap position="float" id="tab2">
<label>Table 2</label>
<caption>
<p>Presenting stroke, radiographic, and intraprocedural metrics.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th/>
<th align="center" valign="top" colspan="2">&#x2264;6 H LKW (<italic>N</italic>&#x2009;=&#x2009;216)</th>
<th align="center" valign="top" colspan="2">6&#x2013;24 H LKW (<italic>N</italic>&#x2009;=&#x2009;189)</th>
<th align="center" valign="top">Value of <italic>p</italic></th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="bottom">Last known well, median (IQR)</td>
<td align="center" valign="bottom">99.5</td>
<td align="center" valign="bottom">(40&#x2013;223.5)</td>
<td align="center" valign="bottom">698</td>
<td align="center" valign="bottom">(515&#x2013;946)</td>
<td align="center" valign="bottom">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="bottom">Initial NIHSS, median (IQR)</td>
<td align="center" valign="bottom">20</td>
<td align="center" valign="bottom">(9&#x2013;27)</td>
<td align="center" valign="bottom">16</td>
<td align="center" valign="bottom">(7&#x2013;25)</td>
<td align="center" valign="bottom">0.071</td>
</tr>
<tr>
<td align="left" valign="bottom">NIHSS &#x2264;10</td>
<td align="center" valign="bottom">65</td>
<td align="center" valign="bottom">(30.1%)</td>
<td align="center" valign="bottom">65</td>
<td align="center" valign="bottom">(34.4%)</td>
<td align="center" valign="bottom">0.109</td>
</tr>
<tr>
<td align="left" valign="bottom">NIHSS 11&#x2013;20</td>
<td align="center" valign="bottom">45</td>
<td align="center" valign="bottom">(20.8%)</td>
<td align="center" valign="bottom">51</td>
<td align="center" valign="bottom">(27.0%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">NIHSS &#x003E;20</td>
<td align="center" valign="bottom">101</td>
<td align="center" valign="bottom">(46.8%)</td>
<td align="center" valign="bottom">70</td>
<td align="center" valign="bottom">(37.0%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">pc-ASPECTS, median (IQR)</td>
<td align="center" valign="bottom">10</td>
<td align="center" valign="bottom">(8&#x2013;10)</td>
<td align="center" valign="bottom">9</td>
<td align="center" valign="bottom">(8&#x2013;10)</td>
<td align="center" valign="bottom">0.103</td>
</tr>
<tr>
<td align="left" valign="bottom">pc-ASPECTS &#x2264;8 (N, %)</td>
<td align="center" valign="bottom">52</td>
<td align="center" valign="bottom">(24.1%)</td>
<td align="center" valign="bottom">44</td>
<td align="center" valign="bottom">(23.3%)</td>
<td align="center" valign="bottom">0.243</td>
</tr>
<tr>
<td align="left" valign="bottom">pc-ASPECTS &#x003E;8 (N, %)</td>
<td align="center" valign="bottom">119</td>
<td align="center" valign="bottom">(55.1%)</td>
<td align="center" valign="bottom">75</td>
<td align="center" valign="bottom">(39.7%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">Anterior&#x2013;posterior collateralization (N, %)</td>
<td align="center" valign="bottom">102</td>
<td align="center" valign="bottom">(47.2%)</td>
<td align="center" valign="bottom">75</td>
<td align="center" valign="bottom">(39.7%)</td>
<td align="center" valign="bottom">0.127</td>
</tr>
<tr>
<td align="left" valign="bottom">Location (N, %)</td>
<td/>
<td/>
<td/>
<td/>
<td align="center" valign="bottom">0.481</td>
</tr>
<tr>
<td align="left" valign="bottom">Proximal</td>
<td align="center" valign="bottom">32</td>
<td align="center" valign="bottom">(14.8%)</td>
<td align="center" valign="bottom">29</td>
<td align="center" valign="bottom">(15.3%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">Middle</td>
<td align="center" valign="bottom">32</td>
<td align="center" valign="bottom">(14.8%)</td>
<td align="center" valign="bottom">19</td>
<td align="center" valign="bottom">(10.1%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">Distal</td>
<td align="center" valign="bottom">104</td>
<td align="center" valign="bottom">(48.1%)</td>
<td align="center" valign="bottom">69</td>
<td align="center" valign="bottom">(36.5%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">Tandem occlusion (N, %)</td>
<td align="center" valign="bottom">27</td>
<td align="center" valign="bottom">(12.5%)</td>
<td align="center" valign="bottom">20</td>
<td align="center" valign="bottom">(10.6%)</td>
<td align="center" valign="bottom">0.903</td>
</tr>
<tr>
<td align="left" valign="bottom">Thrombolysis (N, %)</td>
<td align="center" valign="bottom">87</td>
<td align="center" valign="bottom">(40.3%)</td>
<td align="center" valign="bottom">15</td>
<td align="center" valign="bottom">(7.9%)</td>
<td align="center" valign="bottom">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="bottom">Door to IV thrombolysis, mins (Median, IQR)</td>
<td align="center" valign="bottom">59</td>
<td align="center" valign="bottom">(43&#x2013;103)</td>
<td align="center" valign="bottom">24</td>
<td align="center" valign="bottom">(9&#x2013;79)</td>
<td align="center" valign="bottom">0.253</td>
</tr>
<tr>
<td align="left" valign="bottom">Door to puncture, mins, median (IQR)</td>
<td align="center" valign="bottom">80</td>
<td align="center" valign="bottom">(40&#x2013;139)</td>
<td align="center" valign="bottom">100</td>
<td align="center" valign="bottom">(56&#x2013;142)</td>
<td align="center" valign="bottom">0.906</td>
</tr>
<tr>
<td align="left" valign="bottom">Puncture to recanalization, mins (Median, IQR)</td>
<td align="center" valign="bottom">38.5</td>
<td align="center" valign="bottom">(19&#x2013;60)</td>
<td align="center" valign="bottom">39</td>
<td align="center" valign="bottom">(23&#x2013;74.5)</td>
<td align="center" valign="bottom">0.389</td>
</tr>
<tr>
<td align="left" valign="bottom">Total number of passes (Median, IQR)</td>
<td align="center" valign="bottom">1</td>
<td align="center" valign="bottom">(1&#x2013;3)</td>
<td align="center" valign="bottom">1</td>
<td align="center" valign="bottom">(1&#x2013;3)</td>
<td align="center" valign="bottom">0.921</td>
</tr>
<tr>
<td align="left" valign="bottom">Intra-arterial thrombolysis (N, %)</td>
<td align="center" valign="bottom">16</td>
<td align="center" valign="bottom">(7.4%)</td>
<td align="center" valign="bottom">12</td>
<td align="center" valign="bottom">(6.3%)</td>
<td align="center" valign="bottom">0.675</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="sec13">
<title>Intra-procedural metrics</title>
<p>Patients had door-to-puncture times within 85&#x2009;min (IQR 46&#x2013;142) and puncture-to-recanalization times within 39&#x2009;min (IQR 22&#x2013;69). There were 330 (82%) patients with successful recanalization within our cohort and 154 (38%) achieved recanalization at first pass. Twenty-eight (7%) patients received adjunctive IA thrombolysis.</p>
</sec>
<sec id="sec14">
<title>Functional outcomes</title>
<p>One hundred seventy-eight (44%) patients achieved favorable functional outcomes with 99 (46%) patients in the early time window and 79 (42%) patients in the late time window (<italic>p</italic>&#x2009;=&#x2009;0.41). See <xref ref-type="table" rid="tab3">Table 3</xref> for primary, secondary, and safety cohorts and adjusted analysis. There was an insignificant trend toward unfavorable functional outcomes (mRS&#x2009;&#x2264;&#x2009;3) in the late time window cohort (OR: 1.18; 95% CI: 0.80&#x2013;1.75; <italic>p</italic>&#x2009;=&#x2009;0.42), and despite controlling for potentially confounding factors, significance was not obtained (OR: 0.74; 95% CI: 0.46&#x2013;1.19; <italic>p</italic>&#x2009;=&#x2009;0.22). Shift analysis did not reveal any difference between the two cohorts (OR: 0.49; 95% CI: &#x2212;0.48&#x2013;0.22; <italic>p</italic>&#x2009;=&#x2009;0.47). Receiver&#x2013;operator characteristic (ROC) curve analysis evaluating the time of LKW correlated to the state variable (primary outcome) showed an area under the curve of 0.537. Furthermore, ROC analysis isolating patients with and without AP collateralization did not yield the time of LKW as a predictor of favorable functional outcomes (AUC: 0.550 and 0.495, respectively). NIHSS at 24&#x2009;h was similar between the two cohorts (10 vs. 9; <italic>p</italic>&#x2009;=&#x2009;0.59). See <xref ref-type="fig" rid="fig2">Figure 2</xref> for the probability of favorable functional outcomes as a function of time within the acute time window. See <xref ref-type="fig" rid="fig3">Figure 3</xref> for the mRS shift analysis for early and late time windows with respect to the occlusion site. There was a 4% relative decrease in odds of favorable functional outcomes (<italic>p</italic>&#x2009;=&#x2009;0.038) and functional independence (<italic>p</italic>&#x2009;=&#x2009;0.027) as time progressed in the first 8&#x2009;h (<xref ref-type="fig" rid="fig3">Figure 3</xref>) for every 10-min delay in groin puncture after adjusting for pc-ASPECTS, initial NIHSS, pre-morbid mRS, and proximal clot location.</p>
<table-wrap position="float" id="tab3">
<label>Table 3</label>
<caption>
<p>Primary and secondary outcomes.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th/>
<th align="center" valign="middle" colspan="2">&#x2264;6 H LKW (<italic>N</italic>&#x2009;=&#x2009;216)</th>
<th align="center" valign="middle" colspan="2">6&#x2013;24 H LKW (<italic>N</italic>&#x2009;=&#x2009;189)</th>
<th align="center" valign="middle">Value of <italic>p</italic></th>
<th align="center" valign="middle" colspan="3">Adjusted regression analysis&#x002A;&#x002A;</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="bottom">Primary outcomes</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td align="center" valign="bottom">OR</td>
<td align="center" valign="bottom">95% CI</td>
<td align="center" valign="bottom">Value of <italic>p</italic></td>
</tr>
<tr>
<td align="left" valign="bottom">mRS&#x2009;&#x2264;&#x2009;3 (N, %)</td>
<td align="center" valign="bottom">99</td>
<td align="center" valign="bottom">(45.8%)</td>
<td align="center" valign="bottom">79</td>
<td align="center" valign="bottom">(41.8%)</td>
<td align="center" valign="bottom">0.414</td>
<td align="center" valign="bottom">0.74</td>
<td align="center" valign="bottom">(0.46&#x2013;1.19)</td>
<td align="center" valign="bottom">0.22</td>
</tr>
<tr>
<td align="left" valign="bottom">Secondary outcomes</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">mRS&#x2009;&#x2264;&#x2009;2 (N, %)</td>
<td align="center" valign="bottom">74</td>
<td align="center" valign="bottom">(34.3%)</td>
<td align="center" valign="bottom">60</td>
<td align="center" valign="bottom">(31.7%)</td>
<td align="center" valign="bottom">0.592</td>
<td align="center" valign="bottom">0.93</td>
<td align="center" valign="bottom">(0.56&#x2013;1.53)</td>
<td align="center" valign="bottom">0.77</td>
</tr>
<tr>
<td align="left" valign="bottom">24H NIHSS (Median, IQR)</td>
<td align="center" valign="bottom">10</td>
<td align="center" valign="bottom">(3&#x2013;19)</td>
<td align="center" valign="bottom">9</td>
<td align="center" valign="bottom">(4&#x2013;20)</td>
<td align="center" valign="bottom">0.594</td>
<td align="center" valign="bottom">1.45</td>
<td align="center" valign="bottom">(&#x2212;0.74&#x2013;3.63)</td>
<td align="center" valign="bottom">0.19</td>
</tr>
<tr>
<td align="left" valign="bottom">TICI score&#x2009;&#x2265;&#x2009;2b (N, %)</td>
<td align="center" valign="bottom">180</td>
<td align="center" valign="bottom">(83.3%)</td>
<td align="center" valign="bottom">149</td>
<td align="center" valign="bottom">(78.8%)</td>
<td align="center" valign="bottom">0.365</td>
<td align="center" valign="bottom">1.40</td>
<td align="center" valign="bottom">(0.73&#x2013;2.66)</td>
<td align="center" valign="bottom">0.31</td>
</tr>
<tr>
<td align="left" valign="bottom">Recanalization at first pass (N, %)</td>
<td align="center" valign="bottom">85</td>
<td align="center" valign="bottom">(39.4%)</td>
<td align="center" valign="bottom">68</td>
<td align="center" valign="bottom">(36.0%)</td>
<td align="center" valign="bottom">0.745</td>
<td align="center" valign="bottom">0.99</td>
<td align="center" valign="bottom">(0.61&#x2013;1.60)</td>
<td align="center" valign="bottom">0.97</td>
</tr>
<tr>
<td align="left" valign="bottom">Safety outcomes</td>
<td/>
<td/>
<td/>
<td/>
<td align="center" valign="bottom">0.661</td>
<td/>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">Total ICH (N, %)</td>
<td align="center" valign="bottom">39</td>
<td align="center" valign="bottom">(18.1%)</td>
<td align="center" valign="bottom">31</td>
<td align="center" valign="bottom">(16.4%)</td>
<td align="center" valign="bottom">0.490</td>
<td align="center" valign="bottom">1.15</td>
<td align="center" valign="bottom">(0.64&#x2013;3.31)</td>
<td align="center" valign="bottom">0.65</td>
</tr>
<tr>
<td align="left" valign="bottom">Symptomatic ICH (N, %)</td>
<td align="center" valign="bottom">15</td>
<td align="center" valign="bottom">(6.9%)</td>
<td align="center" valign="bottom">10</td>
<td align="center" valign="bottom">(5.3%)</td>
<td align="center" valign="bottom">0.686</td>
<td align="center" valign="bottom">1.20</td>
<td align="center" valign="bottom">(0.47&#x2013;3.04)</td>
<td align="center" valign="bottom">0.71</td>
</tr>
<tr>
<td align="left" valign="bottom">Intraprocedural perforation (N, %)</td>
<td align="center" valign="bottom">8</td>
<td align="center" valign="bottom">(3.7%)</td>
<td align="center" valign="bottom">5</td>
<td align="center" valign="bottom">(2.6%)</td>
<td align="center" valign="bottom">0.827</td>
<td align="center" valign="bottom">1.31</td>
<td align="center" valign="bottom">(0.33&#x2013;5.34)</td>
<td align="center" valign="bottom">0.69</td>
</tr>
<tr>
<td align="left" valign="bottom">Neurological complications (N, %)</td>
<td align="center" valign="bottom">17</td>
<td align="center" valign="bottom">(7.9%)</td>
<td align="center" valign="bottom">16</td>
<td align="center" valign="bottom">(8.5%)</td>
<td align="center" valign="bottom">0.827</td>
<td align="center" valign="bottom">0.89</td>
<td align="center" valign="bottom">(0.39&#x2013;2.04)</td>
<td align="center" valign="bottom">0.78</td>
</tr>
<tr>
<td align="left" valign="bottom">Hospital complications (N, %)</td>
<td align="center" valign="bottom">49</td>
<td align="center" valign="bottom">(22.7%)</td>
<td align="center" valign="bottom">25</td>
<td align="center" valign="bottom">(13.2%)</td>
<td align="center" valign="bottom">0.014</td>
<td align="center" valign="bottom">2.23</td>
<td align="center" valign="bottom">(1.21&#x2013;4.08)</td>
<td align="center" valign="bottom">0.01</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>&#x002A;&#x002A;Logistic and linear regression analysis was performed for binary and continuous variables, respectively. Adjusted analysis was controlled for potentially confounding factors (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.2) and includes smoking status, diabetes, atrial fibrillation, presenting NIHSS (groups), pc-ASPECTS, anterior&#x2013;posterior collateralization, and IV thrombolysis.</p>
</table-wrap-foot>
</table-wrap>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption>
<p>Probability of favorable functional outcomes as a function of time.</p>
</caption>
<graphic xlink:href="fneur-15-1352310-g002.tif"/>
</fig>
<fig position="float" id="fig3">
<label>Figure 3</label>
<caption>
<p>Modified rankin scale shift analysis for early and late time windows with respect to occlusion site.</p>
</caption>
<graphic xlink:href="fneur-15-1352310-g003.tif"/>
</fig>
</sec>
<sec id="sec15">
<title>Safety profiles</title>
<p>Overall, 70 patients suffered from ICH with 25 (36%) being sICH. The proportion of sICH (6.9% vs. 5.3%; <italic>p</italic>&#x2009;=&#x2009;0.69) was similar between early and late time window patients. There were no differences in neurological complications (8% vs. 9%; <italic>p</italic>&#x2009;=&#x2009;0.83) between the two groups; however, there was a higher proportion of hospital complications in the early time window group (23% vs. 13%; <italic>p</italic>&#x2009;=&#x2009;0.01). Specifically, there were higher rates of infectious complications in the earlier thrombectomy time window (13.4% vs. 4.6%). Logistic regression for hospital complications was significant before (OR: 1.93; 95% CI: 1.16&#x2013;3.20; <italic>p</italic>&#x2009;=&#x2009;0.01) and after adjusting for potentially confounding factors (OR: 2.33; 95% CI: 1.21&#x2013;4.08; <italic>p</italic>&#x2009;=&#x2009;0.01).</p>
</sec>
</sec>
<sec sec-type="discussion" id="sec16">
<title>Discussion</title>
<p>Several randomized controlled trials have recently proved mechanical thrombectomy benefits in BAO in the late time window (<xref ref-type="bibr" rid="ref7 ref8 ref9 ref10">7&#x2013;10</xref>). Our results demonstrate that there is a thrombectomy benefit regardless of the time window. Similar to the aforementioned clinical trials, we opted to use mRS of 0&#x2013;3 to determine favorable outcomes given the high morbidity and mortality of BAO (<xref ref-type="bibr" rid="ref9">9</xref>, <xref ref-type="bibr" rid="ref10">10</xref>). We determined that our early and late time window cohorts achieved similar favorable outcome rates (46% vs. 42%) and are comparable to the rate of outcomes in the recent RCTs (<xref ref-type="bibr" rid="ref9">9</xref>, <xref ref-type="bibr" rid="ref10">10</xref>). This study reaffirms the findings of the BEST, BAOCHE, and ATTENTION trials, which have similar rates of favorable functional outcome and sICH despite patient presentation in different time windows. Within the early time window, however, our study still emphasizes the importance of timely thrombectomy. Saver et al. performed a meta-analysis of anterior circulation large-vessel occlusions and showed that for every 4-min delay in reperfusion the proportion of functional independence decreases by 1% (<xref ref-type="bibr" rid="ref13">13</xref>). In our study, the rate of functional independence (mRS 0&#x2013;2) at 3&#x2009;months declined from 37.3% with an LKW-to-reperfusion time of 120&#x2009;min to 20.9% with an LKW-to-reperfusion time of 480&#x2009;min. Our results further stress this conclusion by demonstrating that for every 10-min groin-puncture delay leads to diminished favorable functional outcome and functional independence by 4% within the first 6&#x2009;h from last seen normal. Many hypotheses for these minor differences exist including eloquence of brain tissue affected, level of macro/microvascular collateralization, density of cranial nerve motor neurons, and capacity of individual nerves to withstand ischemic insults (<xref ref-type="bibr" rid="ref14 ref15 ref16 ref17">14&#x2013;17</xref>).</p>
<p>Patients with intact AP collateralization are expected to react differently to an ischemic event compared to patients without AP collateralization (<xref ref-type="bibr" rid="ref18">18</xref>, <xref ref-type="bibr" rid="ref19">19</xref>). Our study explored this hypothesis using ROC curves with respect to collateralization status and did not demonstrate a predictive value for our early vs. late time window cohorts (AUC: 0.550 and 0.495, respectively). This is most likely a reflection of patients within the cohort. &#x201C;Fast&#x201D; and &#x201C;slow&#x201D; progressors constitute our early time window population; however, as the &#x201C;fast&#x201D; progressors complete their stroke, they are effectively excluded as a thrombectomy candidate leaving the &#x201C;slow&#x201D; progressors in the late time window. This leaves an important unanswered question as to what differentiates &#x201C;slow&#x201D; vs. &#x201C;fast&#x201D; progressing posterior circulation strokes. It is hypothesized that outcomes could be a function of sub-occlusive/occlusive thrombi, clot location, microvascular collateralization, and LKW to recanalization (<xref ref-type="bibr" rid="ref14">14</xref>, <xref ref-type="bibr" rid="ref20">20</xref>). Our subgroup analysis comparing clot location and early vs. late time window cohorts did not show appreciable differences in the shift toward improvement. Unfortunately, our registry did not have data points for sub-occlusive/occlusive thrombi or include measurement of cerebellar artery collaterals or CT perfusion studies to evaluate collateralization, and further studies may help to delineate these patient subtypes.</p>
<p>In terms of peri-procedural outcomes, our early vs. late time window cohorts did not influence an operator&#x2019;s ability to achieve successful recanalization (83% vs. 79%) or recanalization at the first pass (39% vs. 36%). This was similar to the recent posterior circulation randomized controlled trials, which had 88&#x2013;91% successful recanalization (albeit vessel patency was defined differently in these studies) (<xref ref-type="bibr" rid="ref9">9</xref>, <xref ref-type="bibr" rid="ref10">10</xref>). Mokin et al. retrospectively evaluated 100 patients who received mechanical thrombectomy within 12&#x2009;h and demonstrated that time metrics are associated with both improved successful recanalization rates and long-term (12&#x2009;months) functional outcomes (<xref ref-type="bibr" rid="ref21">21</xref>). The main difference in this study is that stroke symptom onset to femoral artery puncture was the main time metric, and the primary outcome was mRS 0&#x2013;2. The differences in the aforementioned study can account for the variable results seen between BAOCHE and ATTENTION trials as well as in this study.</p>
<p>Despite the early time window presenting with a higher presenting NIHSS, the 24-h NIHSS (10 vs. 9) was similar between the early and late cohorts following thrombectomy. Compared to the ATTENTION trial, our dataset had a lower presenting NIHSS and 24-h NIHSS (<xref ref-type="bibr" rid="ref9">9</xref>). As our dataset includes patients treated before the publication of the BAO endovascular trials, it is likely that patients presenting with a worse PC-ASPECT were not offered thrombectomy resulting in selection bias. However, it is apparent that thrombectomy results in an improvement in NIHSS despite the time window presentation.</p>
<p>Interestingly, our study demonstrated higher rates of in-hospital complications in the early time window group. Although not statistically significant, it was observed that these patients presented with a higher NIHSS. As the NIHSS has limitations in the posterior ischemic stroke, patients in the early time window presented with examinations affecting consciousness compared to those in the late time window which had a higher predominance of hemiparesis and sensory loss. This hypothesis is reflected in our data set in which early time window patients were more likely to require intubation for neurological failure (47.9% vs. 33.9%) and suffered from higher rates of infection (13.4% vs. 4.6%) compared to patients in the late time window.</p>
<p>Strengths of this study include its heterogeneous North American population, variety of stroke etiologies, and reasonably high rates of successful recanalization and recanalization at first pass. This study has several limitations. This study derived data which were obtained from a retrospective registry. Patients with low pc-ASPECTS were likely excluded from intervention, which may have resulted in a higher proportion of patients that are &#x201C;slow progressors.&#x201D; We did not have NIHSS inclusion criteria, which means that patients with low NIHSS would possibly have been excluded as well.</p>
</sec>
<sec sec-type="conclusions" id="sec17">
<title>Conclusion</title>
<p>This study shows that in the North American population, select basilar artery thrombectomy patients in the late time window achieve similar rates of favorable outcomes compared to patients within the early time window. We also demonstrated that approximately every 10&#x2009;min of delayed recanalization results in a 4% relative reduction in favorable functional outcome and functional independence within the first 8&#x2009;h from last seen normal. Further studies are required to determine whether outcomes may vary in BAO patients with varying presentations with different pc-ASPECTS or NIHSS on presentation and also in the time window beyond 24&#x2009;h.</p>
</sec>
<sec sec-type="data-availability" id="sec18">
<title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec sec-type="ethics-statement" id="sec19">
<title>Ethics statement</title>
<p>The studies involving humans were approved by the University of Toledo Bioethics Committee. The studies were conducted in accordance with the local legislation and institutional requirements. The ethics committee/institutional review board waived the requirement of written informed consent for participation from the participants or the participants&#x2019; legal guardians/next of kin because this was an observational retrospective design.</p>
</sec>
<sec sec-type="author-contributions" id="sec20">
<title>Author contributions</title>
<p>AM: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Supervision, Visualization, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. RR: Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. SA: Writing &#x2013; review &#x0026; editing. AN: Writing &#x2013; review &#x0026; editing. SO: Writing &#x2013; review &#x0026; editing. JV-S: Writing &#x2013; review &#x0026; editing. MF: Writing &#x2013; review &#x0026; editing. AJ: Writing &#x2013; review &#x0026; editing. SD: Writing &#x2013; review &#x0026; editing. GT: Writing &#x2013; review &#x0026; editing. AA: Writing &#x2013; review &#x0026; editing. TN: Writing &#x2013; review &#x0026; editing. PK: Writing &#x2013; review &#x0026; editing. MA: Writing &#x2013; review &#x0026; editing. HS: Writing &#x2013; review &#x0026; editing. AP: Writing &#x2013; review &#x0026; editing. ZW: Writing &#x2013; review &#x0026; editing. SK: Writing &#x2013; review &#x0026; editing. NV: Writing &#x2013; review &#x0026; editing. NA: Writing &#x2013; review &#x0026; editing. KG: Writing &#x2013; review &#x0026; editing. EA: Writing &#x2013; review &#x0026; editing. SZ: Writing &#x2013; review &#x0026; editing. MJ: Writing &#x2013; review &#x0026; editing.</p>
</sec>
</body>
<back>
<sec sec-type="funding-information" id="sec21">
<title>Funding</title>
<p>The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.</p>
</sec>
<sec sec-type="COI-statement" id="sec22">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="sec100" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="ref1"><label>1.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saver</surname> <given-names>JL</given-names></name></person-group>. <article-title>Time is brain--quantified</article-title>. <source>Stroke</source>. (<year>2006</year>) <volume>37</volume>:<fpage>263</fpage>&#x2013;<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.1161/01.STR.0000196957.55928.ab</pub-id></citation></ref>
<ref id="ref2"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goyal</surname> <given-names>M</given-names></name> <name><surname>Menon</surname> <given-names>BK</given-names></name> <name><surname>van Zwam</surname> <given-names>WH</given-names></name> <name><surname>Dippel</surname> <given-names>DW</given-names></name> <name><surname>Mitchell</surname> <given-names>PJ</given-names></name> <name><surname>Demchuk</surname> <given-names>AM</given-names></name> <etal/></person-group>. <article-title>Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials</article-title>. <source>Lancet</source>. (<year>2016</year>) <volume>387</volume>:<fpage>1723</fpage>&#x2013;<lpage>31</lpage>. doi: <pub-id pub-id-type="doi">10.1016/s0140-6736(16)00163-x</pub-id>, PMID: <pub-id pub-id-type="pmid">26898852</pub-id></citation></ref>
<ref id="ref3"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nogueira</surname> <given-names>RG</given-names></name> <name><surname>Jadhav</surname> <given-names>AP</given-names></name> <name><surname>Haussen</surname> <given-names>DC</given-names></name> <name><surname>Bonafe</surname> <given-names>A</given-names></name> <name><surname>Budzik</surname> <given-names>RF</given-names></name> <name><surname>Bhuva</surname> <given-names>P</given-names></name> <etal/></person-group>. <article-title>Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct</article-title>. <source>N Engl J Med</source>. (<year>2018</year>) <volume>378</volume>:<fpage>11</fpage>&#x2013;<lpage>21</lpage>. doi: <pub-id pub-id-type="doi">10.1056/NEJMoa1706442</pub-id>, PMID: <pub-id pub-id-type="pmid">29129157</pub-id></citation></ref>
<ref id="ref4"><label>4.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Albers</surname> <given-names>GW</given-names></name> <name><surname>Marks</surname> <given-names>MP</given-names></name> <name><surname>Kemp</surname> <given-names>S</given-names></name> <name><surname>Christensen</surname> <given-names>S</given-names></name> <name><surname>Tsai</surname> <given-names>JP</given-names></name> <name><surname>Ortega-Gutierrez</surname> <given-names>S</given-names></name> <etal/></person-group>. <article-title>Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging</article-title>. <source>N Engl J Med</source>. (<year>2018</year>) <volume>378</volume>:<fpage>708</fpage>&#x2013;<lpage>18</lpage>. doi: <pub-id pub-id-type="doi">10.1056/NEJMoa1713973</pub-id>, PMID: <pub-id pub-id-type="pmid">29364767</pub-id></citation></ref>
<ref id="ref5"><label>5.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kleindorfer</surname> <given-names>DO</given-names></name> <name><surname>Towfighi</surname> <given-names>A</given-names></name> <name><surname>Chaturvedi</surname> <given-names>S</given-names></name> <name><surname>Cockroft</surname> <given-names>KM</given-names></name> <name><surname>Gutierrez</surname> <given-names>J</given-names></name> <name><surname>Lombardi-Hill</surname> <given-names>D</given-names></name> <etal/></person-group>. <article-title>2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association</article-title>. <source>Stroke</source>. (<year>2021</year>) <volume>52</volume>:<fpage>e364</fpage>&#x2013;<lpage>467</lpage>. doi: <pub-id pub-id-type="doi">10.1161/STR.0000000000000375</pub-id>, PMID: <pub-id pub-id-type="pmid">34024117</pub-id></citation></ref>
<ref id="ref6"><label>6.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname> <given-names>WS</given-names></name></person-group>. <article-title>Intra-arterial thrombolytic therapy for acute basilar occlusion: pro</article-title>. <source>Stroke</source>. (<year>2007</year>) <volume>38</volume>:<fpage>701</fpage>&#x2013;<lpage>3</lpage>. doi: <pub-id pub-id-type="doi">10.1161/01.Str.0000247897.33267.42</pub-id></citation></ref>
<ref id="ref7"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Langezaal</surname> <given-names>LCM</given-names></name> <name><surname>van der Hoeven</surname> <given-names>E</given-names></name> <name><surname>Mont'Alverne</surname> <given-names>FJA</given-names></name> <name><surname>de Carvalho</surname> <given-names>JJF</given-names></name> <name><surname>Lima</surname> <given-names>FO</given-names></name> <name><surname>Dippel</surname> <given-names>DWJ</given-names></name> <etal/></person-group>. <article-title>Endovascular therapy for stroke due to basilar-artery occlusion</article-title>. <source>N Engl J Med</source>. (<year>2021</year>) <volume>384</volume>:<fpage>1910</fpage>&#x2013;<lpage>20</lpage>. doi: <pub-id pub-id-type="doi">10.1056/NEJMoa2030297</pub-id></citation></ref>
<ref id="ref8"><label>8.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>X</given-names></name> <name><surname>Dai</surname> <given-names>Q</given-names></name> <name><surname>Ye</surname> <given-names>R</given-names></name> <name><surname>Zi</surname> <given-names>W</given-names></name> <name><surname>Liu</surname> <given-names>Y</given-names></name> <name><surname>Wang</surname> <given-names>H</given-names></name> <etal/></person-group>. <article-title>Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial</article-title>. <source>Lancet Neurol</source>. (<year>2020</year>) <volume>19</volume>:<fpage>115</fpage>&#x2013;<lpage>22</lpage>. doi: <pub-id pub-id-type="doi">10.1016/s1474-4422(19)30395-3</pub-id>, PMID: <pub-id pub-id-type="pmid">31831388</pub-id></citation></ref>
<ref id="ref9"><label>9.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tao</surname> <given-names>C</given-names></name> <name><surname>Nogueira</surname> <given-names>RG</given-names></name> <name><surname>Zhu</surname> <given-names>Y</given-names></name> <name><surname>Sun</surname> <given-names>J</given-names></name> <name><surname>Han</surname> <given-names>H</given-names></name> <name><surname>Yuan</surname> <given-names>G</given-names></name> <etal/></person-group>. <article-title>Trial of endovascular treatment of acute basilar-artery occlusion</article-title>. <source>N Engl J Med</source>. (<year>2022</year>) <volume>387</volume>:<fpage>1361</fpage>&#x2013;<lpage>72</lpage>. doi: <pub-id pub-id-type="doi">10.1056/NEJMoa2206317</pub-id></citation></ref>
<ref id="ref10"><label>10.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jovin</surname> <given-names>TG</given-names></name> <name><surname>Li</surname> <given-names>C</given-names></name> <name><surname>Wu</surname> <given-names>L</given-names></name> <name><surname>Wu</surname> <given-names>C</given-names></name> <name><surname>Chen</surname> <given-names>J</given-names></name> <name><surname>Jiang</surname> <given-names>C</given-names></name> <etal/></person-group>. <article-title>Trial of Thrombectomy 6 to 24 hours after stroke due to basilar-artery occlusion</article-title>. <source>N Engl J Med</source>. (<year>2022</year>) <volume>387</volume>:<fpage>1373</fpage>&#x2013;<lpage>84</lpage>. doi: <pub-id pub-id-type="doi">10.1056/NEJMoa2207576</pub-id>, PMID: <pub-id pub-id-type="pmid">36239645</pub-id></citation></ref>
<ref id="ref11"><label>11.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cuschieri</surname> <given-names>S</given-names></name></person-group>. <article-title>The STROBE guidelines</article-title>. <source>Saudi J Anaesth</source>. (<year>2019</year>) <volume>13</volume>:<fpage>31</fpage>&#x2013;<lpage>4</lpage>. doi: <pub-id pub-id-type="doi">10.4103/sja.SJA_543_18</pub-id>, PMID: <pub-id pub-id-type="pmid">30930717</pub-id></citation></ref>
<ref id="ref12"><label>12.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Toni</surname> <given-names>D</given-names></name> <name><surname>Lorenzano</surname> <given-names>S</given-names></name> <name><surname>Puca</surname> <given-names>E</given-names></name> <name><surname>Prencipe</surname> <given-names>M</given-names></name></person-group>. <article-title>The SITS-MOST registry</article-title>. <source>Neurol Sci</source>. (<year>2006</year>) <volume>27</volume>:<fpage>S260</fpage>&#x2013;<lpage>2</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s10072-006-0632-9</pub-id></citation></ref>
<ref id="ref13"><label>13.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saver</surname> <given-names>JL</given-names></name> <name><surname>Goyal</surname> <given-names>M</given-names></name> <name><surname>van der Lugt</surname> <given-names>A</given-names></name> <name><surname>Menon</surname> <given-names>BK</given-names></name> <name><surname>Majoie</surname> <given-names>CBLM</given-names></name> <name><surname>Dippel</surname> <given-names>DW</given-names></name> <etal/></person-group>. <article-title>Time to treatment with endovascular Thrombectomy and outcomes from ischemic stroke: a meta-analysis</article-title>. <source>JAMA</source>. (<year>2016</year>) <volume>316</volume>:<fpage>1279</fpage>&#x2013;<lpage>89</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jama.2016.13647</pub-id></citation></ref>
<ref id="ref14"><label>14.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Desai</surname> <given-names>SM</given-names></name> <name><surname>Tonetti</surname> <given-names>DA</given-names></name> <name><surname>Jovin</surname> <given-names>TG</given-names></name> <name><surname>Jadhav</surname> <given-names>AP</given-names></name></person-group>. <article-title>Fast and slow progressors of infarct growth in basilar artery occlusion strokes</article-title>. <source>J Neurointerv Surg</source>. (<year>2022</year>) <volume>14</volume>:<fpage>neurintsurg-2021-017394</fpage>. doi: <pub-id pub-id-type="doi">10.1136/neurintsurg-2021-017394</pub-id>, PMID: <pub-id pub-id-type="pmid">33766940</pub-id></citation></ref>
<ref id="ref15"><label>15.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rocha</surname> <given-names>M</given-names></name> <name><surname>Desai</surname> <given-names>SM</given-names></name> <name><surname>Jadhav</surname> <given-names>AP</given-names></name> <name><surname>Jovin</surname> <given-names>TG</given-names></name></person-group>. <article-title>Prevalence and temporal distribution of fast and slow progressors of infarct growth in large vessel occlusion stroke</article-title>. <source>Stroke</source>. (<year>2019</year>) <volume>50</volume>:<fpage>2238</fpage>&#x2013;<lpage>40</lpage>. doi: <pub-id pub-id-type="doi">10.1161/strokeaha.118.024035</pub-id></citation></ref>
<ref id="ref16"><label>16.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Desai</surname> <given-names>SM</given-names></name> <name><surname>Rocha</surname> <given-names>M</given-names></name> <name><surname>Jovin</surname> <given-names>TG</given-names></name> <name><surname>Jadhav</surname> <given-names>AP</given-names></name></person-group>. <article-title>High variability in neuronal loss</article-title>. <source>Stroke</source>. (<year>2019</year>) <volume>50</volume>:<fpage>34</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1161/strokeaha.118.023499</pub-id></citation></ref>
<ref id="ref17"><label>17.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shu</surname> <given-names>L</given-names></name> <name><surname>Riedel</surname> <given-names>C</given-names></name> <name><surname>Meyne</surname> <given-names>J</given-names></name> <name><surname>Jansen</surname> <given-names>O</given-names></name> <name><surname>Jensen-Kondering</surname> <given-names>U</given-names></name></person-group>. <article-title>Successful recanalization in acute basilar artery occlusion treated with endovascular therapy is independent of thrombus length</article-title>. <source>J Neurointerv Surg</source>. (<year>2017</year>) <volume>9</volume>:<fpage>1047</fpage>&#x2013;<lpage>52</lpage>. doi: <pub-id pub-id-type="doi">10.1136/neurintsurg-2016-012634</pub-id></citation></ref>
<ref id="ref18"><label>18.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alemseged</surname> <given-names>F</given-names></name> <name><surname>Shah</surname> <given-names>DG</given-names></name> <name><surname>Diomedi</surname> <given-names>M</given-names></name> <name><surname>Sallustio</surname> <given-names>F</given-names></name> <name><surname>Bivard</surname> <given-names>A</given-names></name> <name><surname>Sharma</surname> <given-names>G</given-names></name> <etal/></person-group>. <article-title>The basilar artery on computed tomography angiography prognostic score for basilar artery occlusion</article-title>. <source>Stroke</source>. (<year>2017</year>) <volume>48</volume>:<fpage>631</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1161/STROKEAHA.116.015492</pub-id></citation></ref>
<ref id="ref19"><label>19.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Singer</surname> <given-names>OC</given-names></name> <name><surname>Berkefeld</surname> <given-names>J</given-names></name> <name><surname>Nolte</surname> <given-names>CH</given-names></name> <name><surname>Bohner</surname> <given-names>G</given-names></name> <name><surname>Haring</surname> <given-names>HP</given-names></name> <name><surname>Trenkler</surname> <given-names>J</given-names></name> <etal/></person-group>. <article-title>Mechanical recanalization in basilar artery occlusion: the ENDOSTROKE study</article-title>. <source>Ann Neurol</source>. (<year>2015</year>) <volume>77</volume>:<fpage>415</fpage>&#x2013;<lpage>24</lpage>. doi: <pub-id pub-id-type="doi">10.1002/ana.24336</pub-id></citation></ref>
<ref id="ref20"><label>20.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fabritius</surname> <given-names>MP</given-names></name> <name><surname>Tiedt</surname> <given-names>S</given-names></name> <name><surname>Puhr-Westerheide</surname> <given-names>D</given-names></name> <name><surname>Grosu</surname> <given-names>S</given-names></name> <name><surname>Maurus</surname> <given-names>S</given-names></name> <name><surname>Schwarze</surname> <given-names>V</given-names></name> <etal/></person-group>. <article-title>Computed tomography perfusion deficit volumes predict functional outcome in patients with basilar artery occlusion</article-title>. <source>Stroke</source>. (<year>2021</year>) <volume>52</volume>:<fpage>2016</fpage>&#x2013;<lpage>23</lpage>. doi: <pub-id pub-id-type="doi">10.1161/STROKEAHA.120.032924</pub-id>, PMID: <pub-id pub-id-type="pmid">33947212</pub-id></citation></ref>
<ref id="ref21"><label>21.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mokin</surname> <given-names>M</given-names></name> <name><surname>Sonig</surname> <given-names>A</given-names></name> <name><surname>Sivakanthan</surname> <given-names>S</given-names></name> <name><surname>Ren</surname> <given-names>Z</given-names></name> <name><surname>Elijovich</surname> <given-names>L</given-names></name> <name><surname>Arthur</surname> <given-names>A</given-names></name> <etal/></person-group>. <article-title>Clinical and procedural predictors of outcomes from the endovascular treatment of posterior circulation strokes</article-title>. <source>Stroke</source>. (<year>2016</year>) <volume>47</volume>:<fpage>782</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1161/STROKEAHA.115.011598</pub-id></citation></ref>
</ref-list>
</back>
</article>